
Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing ... Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 18.2 | 18.2 | 18.2 | 0 | 0 | CS |
4 | 0 | 0 | 18.2 | 18.2 | 18.2 | 0 | 0 | CS |
12 | 0 | 0 | 18.2 | 18.2 | 18.2 | 0 | 0 | CS |
26 | 4.8 | 35.8208955224 | 13.4 | 19 | 12.7 | 47543 | 15.47183724 | CS |
52 | 2.1 | 13.0434782609 | 16.1 | 19.3 | 12.501 | 113673 | 15.92351545 | CS |
156 | -19.1 | -51.2064343164 | 37.3 | 112.95 | 9.801 | 185651 | 29.28142257 | CS |
260 | -134.8 | -88.1045751634 | 153 | 168.3 | 9.801 | 157627 | 35.91555678 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約